Atlas

Form 483

Vera Therapeutics, Inc. Form 483, 2026-03-02

FDA issued a Form 483 to Vera Therapeutics, Inc. on 2026-03-02 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Vera Therapeutics, Inc. · Brisbane, United States · Issued March 2, 2026

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Mar 2026
21 CFR 312.50

General responsibilities of sponsors

Cited by Cynthia J Tsui

2 Mar 2026
21 CFR 312.53(c)(1)

Investigator statement (FDA 1572)

Cited by Cynthia J Tsui

Inspected site

VTVera Therapeutics, Inc.Brisbane, United States

Inspection team

CJCynthia J Tsui

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations1x
21 CFR 312.53(c)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere